Stocks
ImmunoGen (IMGN) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -2.68 | -9.26 | -44.0 | -8.61 | 1.20 | -127.4 | ||
| Changes by years, y/y, % | -156% | +245% | +375% | -80% | -114% | -24.1% | |||
ImmunoGen. EV/EBITDA
ImmunoGen. EV/EBITDA, changes, %
ImmunoGen (IMGN) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| EV/EBITDA | ? | -4.62 | 1.21 | -3.50 | -26.0 | 8.49 | -127.4 | |
| Changes by years, y/y, % | -74% | -114% | -48% | +405% | -284% | |||
| Changes by quarters, q/q, % | -10% | -126% | -390% | +644% | -133% | |||
